Alegret&Laguna Lab

Our research group has a strong background on
dietary models of nutrient-driven metabolic diseases and currently focuses on
the early stage of NAFLD

[Alegret&Laguna Lab @AlegretLab]

As editors of the Carbohydrates section of @Nutrients_MDPI we are thrilled to announce the highly cited papers in 2024-2025

[Alegret&Laguna Lab @AlegretLab]

Very proud of @RbentanachsR , winner of the first prize for the best oral communication at the Research Day @Farmacia_UB @Fedefarma

[Alegret&Laguna Lab @AlegretLab]

@Biomed_MDPI @MDPIBiologySubj Happy to know that our paper is #highcited in #mdpibiomedicines

[Alegret&Laguna Lab @AlegretLab]

@CarlosBocosdeP @AgEInves Thank you!

[Alegret&Laguna Lab @AlegretLab]

We are thrilled to announce that our new project on drug repurposing for liver fibrosis and atherosclerosis will be funded by @AgEInves

[Alegret&Laguna Lab @AlegretLab]

We are glad to share this publication in collaboration with @BButtari et al Sex Differences Affect the NRF2 Signaling Pathway in the Early Phase of Liver Steatosis: A High-Fat-Diet-Fed Rat Model Supplemented with Liquid Fructose https://t.co/ylfKwnQtpL #mdpicells via @Cells_MDPI

[Alegret&Laguna Lab @AlegretLab]

@Toxicology_GRET Ens deixa un gran científic i una gran persona. T'enyorarem molt.

[Alegret&Laguna Lab @AlegretLab]

Happy to share our latest paper on pemafibrate and #MASLD got published in #BiomedPharmacother https://t.co/olxXVi8JwF

[Alegret&Laguna Lab @AlegretLab]

Our article is a #TopDownloadedArticle in Molecular Nutrition & Food Research: ChREBP-driven DNL and PNPLA3 Expression Induced by Liquid Fructose are Essential in the Production of Fatty Liver and Hypertriglyceridemia in a High-Fat Diet-Fed Rat Model

[Alegret&Laguna Lab @AlegretLab]

At the 9th MetNet Internacional Annual Meeting @RbentanachsR

[Alegret&Laguna Lab @AlegretLab]

Proud of our contribution to this special issue of Biomedicines

[Biomedicines MDPI @Biomed_MDPI]

#Successful Special Issue Closed

"#Metabolic and #Genetic Associated #Fatty #Liver Diseases"

contain 13 #OpenAccess papers here：
https://t.co/15LDLpy6Wr

[Biomedicines MDPI @Biomed_MDPI]

#Successful Special Issue Closed

"#Metabolic and #Genetic Associated #Fatty #Liver Diseases"

contain 13 #OpenAccess papers here：
https://t.co/15LDLpy6Wr

[Alegret&Laguna Lab @AlegretLab]

In contrast with female rats, male rats do not develop hepatic steatosis after a high-fat diet supplemented with liquid fructose. Discover why at t'he #EASLCongress

[Alegret&Laguna Lab @AlegretLab]

@RbentanachsR at the #EASLCongress presenting part of his thesis project about the beneficial effects of pemafibrate on hepatic steatosis in female rats

[Alegret&Laguna Lab @AlegretLab]

No todos los ácidos grasos omega 3 son iguales, el Dr Laguna explica por qué en el XXXV Congreso de la @sea_es

[Alegret&Laguna Lab @AlegretLab]

El Dr. Laguna nos lleva de viaje con los triglicéridos en el Congreso @sea_es

[Alegret&Laguna Lab @AlegretLab]

It's a great honor to attend the conference by Dr. Fraser Stoddart, Nobel Prize of Chemistry @sirfrasersays @Farmacia_UB

[Alegret&Laguna Lab @AlegretLab]

La Dra. Roglans ha fet avui un seminari de recerca a @Farmacia_UB explicant els resultats més recents del nostre grup

[Alegret&Laguna Lab @AlegretLab]

Tomorrow, at the 26th MetNet meeting, Roger Bentanachs @RbentanachsR will talk about drug repurposing in NAFLD

[Alegret&Laguna Lab @AlegretLab]

Laia Blanco, winner of the 2nd prize @infarma_es for her research on pemafibrate and #FattyLiver Congrats, Laia! @Farmacia_UB @UniBarcelona